In this process, the change of AT1R level has an obvious impact on the expressions of downstream PLC-β1 and CaM proteins, and PLC-β1 siRNA was used to transfect HCC cells to further confirm the role of the above signaling molecules. The gene discussed is PLCB1; the disease is hepatocellular carcinoma.